Seeking Alpha
 

Imprimis Pharmaceuticals, Inc. (IMMY)

- NASDAQ
  • Dec. 2, 2014, 9:43 AM
    • In a all-stock transaction, Imprimis Pharmaceuticals (IMMY) acquires South Coast Specialty Compounding. As part of the transaction, Park signs a license agreement allowing it to immediately begin making and dispensing Imprimis' ophthalmology and urology formulations in the 13 states where it is currently licensed, including CA, NV, OR and HI.
    • Park will generate almost $4M in top line revenue in 2014.
    • Imprimis acquired its first pharmacy, Pharmacy Creations, LLC, in April 2014.
    | Comment!
Visit Seeking Alpha's
IMMY vs. ETF Alternatives
Company Description
Imprimis Pharmaceuticals Inc is a development stage pharmaceutical company.
Sector: Healthcare
Industry: Biotechnology
Country: United States